Výsledky vyhledávání - "V M, De Benedetti"

Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors

Autor: M C, von Brevern, M C, Hollstein, H M, Cawley, V M, De Benedetti, W P, Bennett, L, Liang, A G, He, S M, Zhu, T, Tursz, N, Janin, G E, Trivers

Publikováno v: Cancer research. 56(21)

Serum antibodies reacting with the tumor suppressor protein p53 have been detected previously in cancer patients with a variety of neoplasms. Two initial (although insufficient) prerequisites for a B-cell response to occur have been proposed: p53 pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::395b356ddbaab1d0314b022a8dfba7ff
https://pubmed.ncbi.nlm.nih.gov/8895744

Zobrazit plný text záznamu

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer

Autor: G E, Trivers, V M, De Benedetti, H L, Cawley, G, Caron, A M, Harrington, W P, Bennett, J R, Jett, T V, Colby, H, Tazelaar, P, Pairolero, R D, Miller, C C, Harris

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 2(10)

Serum anti-p53 antibodies (p53-Abs) may be surrogate markers for both p53 alterations and preclinical cancer. Ancillary to a prospective trial to abate progressive development of clinical stages of chronic obstructive pulmonary disease, we conducted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cb6ea8e40a97fbe27fa7e773c30743cf
https://pubmed.ncbi.nlm.nih.gov/9816128

Zobrazit plný text záznamu

p53 mutations in lung cancer following radiation therapy for Hodgkin's disease

Autor: V M, De Benedetti, L B, Travis, J A, Welsh, F E, van Leeuwen, M, Stovall, E A, Clarke, J D, Boice, W P, Bennett

Publikováno v: Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 5(2)

High risks of lung cancer occur after successful treatment of Hodgkin's disease. In addition to tobacco smoking, other risk factors include radiotherapy, chemotherapy, and immunosuppression, although the relative contributions of each are unknown. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4e9319c0ed21bfdeb4cb6898ad4cc377
https://pubmed.ncbi.nlm.nih.gov/8850268

Zobrazit plný text záznamu

p53 mutations in hepatocellular carcinoma related to oral contraceptive use

Autor: V M, De Benedetti, J A, Welsh, M C, Yu, W P, Bennett

Publikováno v: Carcinogenesis. 17(1)

Oral contraceptives (OCs) are implicated in the development of hepatocellular carcinoma (HCC). Mitogenic stimulation may be the primary mechanism of tumorigenesis, but other factors may also contribute. Mutational spectrum analysis can provide insigh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::82f157e63187a995be9cf39774cfb0d7
https://pubmed.ncbi.nlm.nih.gov/8565124

Zobrazit plný text záznamu

p53 is not mutated in hepatocellular carcinomas from Alaska Natives

Autor: V M, De Benedetti, J A, Welsh, G E, Trivers, A, Harpster, A J, Parkinson, A P, Lanier, B J, McMahon, W P, Bennett

Publikováno v: Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 4(1)

Hepatocellular carcinoma is common among Alaska Natives. The known risk factor in this population is hepatitis B viral infection; fungal toxins, including aflatoxin B1, have not been detected in foodstuffs. In this series of 14 patients (including 4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a97afda391109a653055612ea74b3e85
https://pubmed.ncbi.nlm.nih.gov/7894327

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání